• Issue

    Respirology: Volume 19, Issue 2

    151-293
    February 2014

INVITED REVIEW SERIES

Modern Statistical Methods in Respiratory Medicine

Free Access

Models for the analysis of repeated continuous outcome measures in clinical trials

  • Pages: 155-161
  • First Published: 25 November 2013

ORIGINAL ARTICLES

Free Access

Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: A randomized controlled trial

  • Pages: 193-202
  • First Published: 21 November 2013

The inclusion of disease-specific group education in pulmonary rehabilitation for COPD was evaluated in a randomized controlled trial. Education incorporating self-management did not result in any additional benefit compared with pulmonary rehabilitation without education. These findings support the delivery of simple exercise-based pulmonary rehabilitation programmes when resources are limited.

See Editorial, page 151

The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: A case–control analysis

  • Pages: 203-210
  • First Published: 29 November 2013

Patients with NCFB are characterized by chronic sputum production and an underlying vicious cycle of infection, inflammation and mucus retention. We show that sputum colour assessment is an easy, quick and reliable way that reflects underlying disease severity, proteolytic enzymatic activity/presence and inflammation.

See Editorial, page 153

Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis

  • Pages: 211-217
  • First Published: 27 August 2013

The prevalence of gastro-oesophageal reflux in adults with chronic obstructive pulmonary disease or bronchiectasis is twice as high compared with individuals without lung disease. The findings of this observational study suggest that gastro-oesophageal reflux is a common comorbidity across the disease spectrum in adults with these lung conditions.

Detection of viruses and atypical bacteria associated with acute respiratory infection of children in Hubei, China

  • Pages: 218-224
  • First Published: 20 November 2013

Indirect immunofluorescence assays were performed to detect immunoglobulin M antibodies against nine pathogens to provide an important dataset for use in clinical diagnoses and the development of more effective therapeutic regimens in the future.

Inflammatory markers and pulmonary granuloma infiltration in sarcoidosis

  • Pages: 225-230
  • First Published: 24 December 2013

This study demonstrated β-glucan—a fungal cell wall agent—in the lungs of sarcoidosis patients. It also confirmed a positive relationship between β-glucan and domestic fungi exposure. Lung granuloma infiltration correlated inflammatory cytokines except IL-10, an anti-granuloma cytokine.

Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: A 26-week Asia-Pacific study

  • Pages: 231-238
  • First Published: 03 January 2014

We investigated the effect of indacaterol on FEV1, dyspnoea and health-related quality of life in a predominantly Chinese population diagnosed with moderate-to-severe COPD. Indacaterol proved to be a useful treatment option as it showed effective bronchodilation and improvements in breathlessness and health status in this population.

Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone

  • Pages: 239-245
  • First Published: 25 November 2013

We compared outcome and prognostic factors between CPFE and IPF alone. We found that, survival for individuals with CPFE was significantly worse than that for IPF alone. Especially, CPFE with paraseptal emphysema associated with high esPAP has an extremely poor prognosis.

CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis

  • Pages: 246-252
  • First Published: 20 November 2013

Serum CYFRA 21-1 is useful for the diagnosis of autoimmune pulmonary alveolar proteinosis (APAP) by receiver operating characteristic curve analysis and significantly correlated with other disease severity markers of APAP. Serum CYFRA 21-1 might be a predictor of responsiveness to GM-CSF inhalation therapy in APAP.

High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers

  • Pages: 253-261
  • First Published: 24 December 2013

Our study showed that in individuals with smoking risk factor, high expression of HMGB1 in the blood and lungs is related to the decline of lung function and appears to be associated with the development of COPD.

Association of five genetic variants with chronic obstructive pulmonary disease susceptibility and spirometric phenotypes in a Chinese Han population

  • Pages: 262-268
  • First Published: 29 November 2013

We demonstrate that variants in HTR4 are associated with COPD in never-smokers, and SNP in AGER are associated with lung function in a Chinese Han population.

Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis

  • Pages: 269-275
  • First Published: 20 November 2013

In IPF, pulmonary hypertension is associated with poor prognosis. Cardiopulmonary exercise testing can be used for early detection of a vascular impairment. An increased ventilatory equivalent at anaerobic threshold, a parameter of vascular impairment, was associated with mortality, and may be useful for more accurate prognostic assessment in IPF patients.

Free Access

Nebulization of corticosteroids to asthmatic children: Large variation in dose inhaled

  • Pages: 276-279
  • First Published: 24 November 2013

We investigated if asthmatic children inhale the same proportion of the prescribed dose of fluticasone, beclomethasone dipropionate and flunisolide from the same nebulizer. Results demonstrate that the prescribed dose bears little resemblance to the proportion of drug children inhale and that this is largely dependent on the drug formulation.

Altered sputum granzyme B and granzyme B/proteinase inhibitor-9 in patients with non-eosinophilic asthma

  • Pages: 280-287
  • First Published: 23 December 2013

The non-eosinophilic phenotype of asthma is associated with chronic airway inflammation and airway neutrophilia. The role of granzyme B in NEA is not known. Increased granzyme B expression in NEA may contribute to increased epithelial cell apoptosis, lung injury and chronic inflammation.

FORTHCOMING MEETINGS

Free Access

Forthcoming Meetings

  • Page: 293
  • First Published: 14 January 2014

JOURNAL STATISTICS

Free Access

Journal Statistics

  • Page: 293
  • First Published: 14 January 2014